Prostatic acid phosphatase (PAP) and prostate-specific antigen (PSA) are two immunogenic antigens that are expressed by prostate cancer cells and have both been investigated as potential targets for antigen-based vaccinations [57]. The gene discussed is ACP3; the disease is Familial prostate cancer.